Deutsche Bank
ENZN

Deutsche Bank’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Deutsche Bank’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-420
Closed – – 5537
2016
Q1 		$0 Hold
420
– – ﹤0.01% 5507
2015
Q4 		$0 Hold
420
– – ﹤0.01% 5537
2015
Q3 		$0 Sell
420
-91,784
-100% -$113K ﹤0.01% 5511
2015
Q2 		$110K Buy
92,204
+34,535
+60% +$44K ﹤0.01% 4197
2015
Q1 		$60K Buy
57,669
+57,249
+13,631% +$59.2K ﹤0.01% 4330
2014
Q4 		$0 Hold
420
– – ﹤0.01% 6496
2014
Q3 		$0 Sell
420
-71,574
-99% -$88.4K ﹤0.01% 6284
2014
Q2 		$74K Buy
71,994
+54,363
+308% +$51.8K ﹤0.01% 4737
2014
Q1 		$17K Buy
17,631
+9,483
+116% +$9.79K ﹤0.01% 4896
2013
Q4 		$8K Sell
8,148
-47,288
-85% -$72.8K ﹤0.01% 4947
2013
Q3 		$92K Buy
55,436
+24,623
+80% +$45.6K ﹤0.01% 4460
2013
Q2 		$60K Buy
+30,813
New +$90.2K ﹤0.01% 4446

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Deutsche Bank's ENZN Position: Q2 2016 in Review

Deutsche Bank sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 420 shares.

Deutsche Bank first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $110K in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Deutsche Bank reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Deutsche Bank sold 420 ENZON PHARMACEUTICALS INC shares in Q2 2016.
  • Deutsche Bank first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Deutsche Bank's ENZON PHARMACEUTICALS INC position peaked at $110K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Deutsche Bank's 13F filing for Q2 2016, filed 15 Aug 2016.